BIOLOGIC DETERMINANTS OF PROPRANOLOL DISPOSITION - RESULTS FROM 1308 PATIENTS IN THE BETA-BLOCKER HEART-ATTACK TRIAL

被引：73

作者：

WALLE, T

BYINGTON, RP

FURBERG, CD

MCINTYRE, KM

VOKONAS, PS

机构：

[1] UNIV TEXAS,HLTH SCI CTR,BHAT COORDINATING CTR,HOUSTON,TX 77025

[2] NHLBI,CLIN APPLICAT & PREVENT PROGRAM,BETHESDA,MD 20205

[3] VET ADM HOSP,W ROXBURY,MA

[4] BOSTON UNIV,SCH MED,BOSTON,MA 02118

来源：

CLINICAL PHARMACOLOGY & THERAPEUTICS | 1985年 / 38卷 / 05期

关键词：

D O I：

10.1038/clpt.1985.216

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：509 / 518

页数：10

共 81 条

[61]

SHAH RR, 1982, LANCET, V1, P508

[62] INDIVIDUALIZATION OF PROPRANOLOL THERAPY [J].

SHAND, DG .

MEDICAL CLINICS OF NORTH AMERICA, 1974, 58 (05) :1063-1069

[63] PROPRANOLOL IN SERUM BY HIGH-PRESSURE LIQUID-CHROMATOGRAPHY USING NITRILE (CN) BONDED COLUMNS IN REVERSE PHASE [J].

SIMON, M ;

TERRY, R .

THERAPEUTIC DRUG MONITORING, 1979, 1 (02) :265-276

[64]

SOTANIEMI EA, 1979, CLIN PHARMACOL THER, V26, P153

[65] DIPHENHYDRAMINE IN ORIENTALS AND CAUCASIANS [J].

SPECTOR, R ;

CHOUDHURY, AK ;

CHIANG, CK ;

GOLDBERG, MJ ;

GHONEIM, MM .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1980, 28 (02) :229-234

[66]

TUCKER GT, 1977, LANCET, V2, P718

[67]

VERVLOET E, 1977, CLIN PHARMACOL THER, V22, P853

[68] ASSESSMENT OF METHODS TO IDENTIFY SOURCES OF INTERINDIVIDUAL PHARMACOKINETIC VARIATIONS [J].

VESELL, ES ;

PENNO, MB .

CLINICAL PHARMACOKINETICS, 1983, 8 (05) :378-409

[69]

VESTAL RE, 1979, CLIN PHARMACOL THER, V25, P19

[70]

VESTAL RE, 1979, CLIN PHARMACOL THER, V26, P8

← 1 2 3 4 5 6 7 8 9 →